NCT05215197 Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
| NCT ID | NCT05215197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pamukkale University |
| Condition | Hearing Loss, Sensorineural |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2022-01-31 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2022-01-31 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Eligibility Criteria
Inclusion Criteria: * Patients with sensorineural hearing loss * Patients who will have cochlear implant surgery with CI422 electrode Exclusion Criteria: * Patients with cochlear abnormality * Patients with auditory neuropathy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05215197 clinical trial?
This trial is open to participants of all sexes, studying Hearing Loss, Sensorineural. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05215197 currently recruiting?
Yes, NCT05215197 is actively recruiting participants. Contact the research team at fnardic@pau.edu.tr for enrollment information.
Where is the NCT05215197 trial being conducted?
This trial is being conducted at Denizli, Turkey (Türkiye).
Who is sponsoring the NCT05215197 clinical trial?
NCT05215197 is sponsored by Pamukkale University. The trial plans to enroll 10 participants.